Your browser doesn't support javascript.
loading
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort.
Bowers, Jackson T; Anna, Jacob; Bair, Steven M; Annunzio, Kaitlin; Epperla, Narendranath; Pullukkara, Jerrin Joy; Gaballa, Sameh; Spinner, Michael A; Li, Shuning; Messmer, Marcus R; Nguyen, Joseph; Ayers, Emily C; Wagner, Charlotte B; Hu, Boyu; Di, Mengyang; Huntington, Scott F; Furqan, Fateeha; Shah, Nirav N; Chen, Christina; Ballard, Hatcher J; Hughes, Mitchell E; Chong, Elise A; Nasta, Sunita D; Barta, Stefan K; Landsburg, Daniel J; Svoboda, Jakub.
Afiliação
  • Bowers JT; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Anna J; Division of Hematology, University of Colorado Denver, Aurora, CO.
  • Bair SM; Division of Hematology, University of Colorado Denver, Aurora, CO.
  • Annunzio K; The Ohio State University, Columbus, OH.
  • Epperla N; The Ohio State University, Columbus, OH.
  • Pullukkara JJ; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Gaballa S; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Spinner MA; Division of Hematology Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA.
  • Li S; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.
  • Messmer MR; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.
  • Nguyen J; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.
  • Ayers EC; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.
  • Wagner CB; Division of Hematology/Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Hu B; Division of Hematology/Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Di M; Division of Hematology Oncology, Department of Medicine, Yale University, New Haven, CT.
  • Huntington SF; Division of Hematology Oncology, Department of Medicine, Yale University, New Haven, CT.
  • Furqan F; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI.
  • Shah NN; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI.
  • Chen C; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Ballard HJ; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Hughes ME; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Chong EA; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Nasta SD; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Barta SK; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Landsburg DJ; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Svoboda J; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
Blood Adv ; 7(21): 6630-6638, 2023 11 14.
Article em En | MEDLINE | ID: mdl-37595053
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Doenças do Sistema Nervoso Periférico Tipo de estudo: Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Panamá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Doenças do Sistema Nervoso Periférico Tipo de estudo: Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Panamá